Veracyte, Inc.
VCYT
$59.03
$2.274.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -30.24% | 115.02% | 2,052.76% | -113.91% | 37.83% |
| Total Depreciation and Amortization | 2.49% | 0.61% | -4.06% | 2.37% | -14.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,846.05% | -95.29% | -49.86% | 273.79% | -56.15% |
| Change in Net Operating Assets | -314.07% | -14.14% | 420.39% | 108.45% | -277.09% |
| Cash from Operations | -33.03% | 17.49% | 33.19% | 526.73% | -78.14% |
| Capital Expenditure | 21.64% | -35.39% | -117.11% | 29.30% | 56.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10,560.17% | -97.66% | 4,707.44% | 102.12% | 0.00% |
| Cash from Investing | -2,256.56% | -111.25% | 21,645.98% | 99.57% | 4.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -22.08% | -39.39% | 219.24% | -38.86% | -9.10% |
| Repurchase of Common Stock | -155.92% | -30.03% | -18.24% | 74.82% | -188.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4,348.99% | -105.01% | 625.97% | 91.27% | -43.77% |
| Foreign Exchange rate Adjustments | -583.33% | -80.00% | -89.53% | 674.32% | 118.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -311.49% | -51.05% | 187.70% | 163.16% | -53.11% |